Biotech Attovia Therapeutics Climbs 24% After $289 Million IPO
· financialpost.com
Attovia Therapeutics Inc. shares jumped 24% in its trading debut, after the early-stage drug developer focused on immune system diseases raised $289 million in a US…
Looking for Canada's best finds and deals? Visit Canoe and shop with confidence. Check it out >>
Looking for Canada's best finds and deals? Visit Canoe and sho...